Cancer Imaging welcomes well-described case studies detailing 5 or more cases* that include the following:
•Unreported or unusual side effects or adverse interactions involving medications
•Unexpected or unusual presentations of a disease
•New associations or variations in disease processes
•Presentations, diagnoses and/or management of new and emerging diseases
•An unexpected association between diseases or symptoms
•An unexpected event in the course of observing or treating a patient
•Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
*Cases series reporting 3 or more cases of unusual or new findings in common malignancies will also be considered.
Case series submitted to Cancer Imaging should make a contribution to medical knowledge and must have educational value or highlight the need for a change in clinical practice or diagnostic/prognostic approaches.
Cancer Imaging will not consider case series describing preventive or therapeutic interventions, as these generally require stronger evidence. Case reports will also not be considered.
Authors are encouraged to describe how the case series is rare or unusual as well as its educational and/or scientific merits in the covering letter that accompanies the submission of the manuscript.
For case series, Cancer Imaging requires authors to follow the CARE guidelines. The CARE checklist should be provided as an additional file. Submissions received without these elements will be returned to the authors as incomplete.